Femasys (FEMY) Net Income Growth (1y) (2021 - 2025)
Femasys (FEMY) Net Income Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.79 Bn | 121.57 Bn | 1.96 Bn | 23.94% |
| 2 | Becton Dickinson | 45.00 Bn | 44.18 Bn | 2.15 Bn | -282.67% |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn | - |
| 4 | Medline | 32.87 Bn | 30.63 Bn | 1.84 Bn | -25.78% |
| 5 | Resmed | 29.50 Bn | 27.84 Bn | 890.98 Mn | 9.23% |
| 6 | West Pharmaceutical Services | 23.14 Bn | 22.71 Bn | 329.20 Mn | 16.64% |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn | -90.51% |
| 8 | Cooper Companies | 13.88 Bn | 13.74 Bn | 735.40 Mn | -188.83% |
| 9 | Align Technology | 12.15 Bn | 11.09 Bn | 736.59 Mn | 20.96% |
| 10 | Femasys | 15.09 Mn | 9.70 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.11% |
| Mar 31, 2025 | -63.82% |
| Dec 31, 2024 | -16.17% |
| Sep 30, 2024 | -35.33% |
| Jun 30, 2024 | -61.90% |
| Mar 31, 2024 | -18.27% |
| Dec 31, 2023 | -46.34% |
| Sep 30, 2023 | -30.51% |
| Jun 30, 2023 | -1.82% |
| Mar 31, 2023 | -5.47% |
| Dec 31, 2022 | -27.44% |
| Sep 30, 2022 | -35.53% |
| Jun 30, 2022 | -162.38% |
| Mar 31, 2022 | -57.66% |
| Dec 31, 2021 | -42.50% |
| Sep 30, 2021 | -44.09% |
| Jun 30, 2021 | 27.09% |